Seattle Translational Tumor Research (STTR) creates environments which enable researchers and clinicians to accelerate scientific discovery and translate it into preventions and cures for patients.
We are excited to announce the expansion of STTR programing to include liquid tumor entities within STTR. Desert Horse-Grant will now focus on translational “cancer” research under one umbrella. Four new liquid and one additional solid tumor group into STTR: leukemia, lymphoma, myeloma, myelodysplastic syndromes/myeloproliferative neoplasms, and anogenital cancers.
In this issue of the STTR newsletter, we feature a clinical trial in progress for bladder, brain, breasts, colorectal, head and neck, lung, ovarian, pancreatic, prostate and sarcoma. Also, learn more about our comprehensive online resource database for patients, caregivers, friends and family.
Need Help? New database points cancer patients to no- o rlow-cost resources including transportation, wigs, gentle yoga and summer camps for patients' kids.
STTR Newsletter, Spring 2015
The new year brings new opportunities for our scientists and the world. We were extremely encouraged by the wonderful turnout and community support at the Hutch Gala on December 6, 2014. The money raised at the gala will provide the needed support for innovative and translational research at Fred Hutch. 2015 started with the launch of two new STTR initiatives: STTRconnect and Oncoscape.
STTR's Desert Horse-Grant named 'Disruptive Woman to Watch in 2015'
January 13, 2015
By Mary Engel/Fred Hutch News Service
Desert Horse-Grant, director of strategic planning and operations for Solid Tumor Translational Research (STTR) across Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance, has been named a “Disruptive Woman to Watch in 2015” by Disruptive Women in Health Care, a group that spotlights women whose achievements and ideas advance and improve health care.
Revolutionizing solid tumor treatment
Fred Hutch Quest Magazine, Winter 2013
By Deborah Bach/Fred Hutch News Service
Dr. Eric Holland is a world-renowned brain cancer researcher, a top neurosurgeon and the ideal person to lead Fred Hutch toward precise new tumor therapies.